Clinical Research Directory
Browse clinical research sites, groups, and studies.
Methoxyflurane for IUD Insertion and Endometrial Biopsy
Sponsor: Mount Sinai Hospital, Canada
Summary
The aim of this study is to determine if 3ml of inhaled Methoxyflurane, in the form of a Penthrox inhaler, reduces pain during IUD insertion and/or endometrial biopsy. The proposed study is a double-blind, placebo-controlled RCT. Each participant will be randomly assigned to one of two arms: 1. Intervention (3ml of Methoxyflurane via a Penthrox inhaler) 2. Placebo (3ml of normal saline via an identical placebo Penthrox inhaler) The primary outcome is global pain score, which will be patient-reported by the 100 mm Visual Analogue Scale (VAS) 5-minutes following the procedure (endometrial biopsy or IUD insertion).
Official title: A Double-blind Placebo-controlled Randomized Controlled Trial (RCT) of 3ml Methoxyflurane for Intrauterine Device (IUD) Insertion and Endometrial Biopsy
Key Details
Gender
FEMALE
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
174
Start Date
2025-07-24
Completion Date
2026-03-01
Last Updated
2025-07-30
Healthy Volunteers
Yes
Conditions
Interventions
Methoxyflurane - Penthrox
3ml of Methoxyflurane via a Penthrox inhaler
Placebo Penthrox inhaler
3ml of normal saline via an identical placebo Penthrox inhaler
Locations (1)
OPG
Toronto, Ontario, Canada